SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers
Scienture Holdings, Inc. announced it has completed manufacturing commercial inventory of REZENOPY™ (naloxone hydrochloride) Nasal Spray 10 mg and will begin shipments to U.S. pharmaceutical wholesalers in July, with commercial availability expected in August. REZENOPY™ is the highest-dose FDA-approved naloxone nasal spray designed to treat opioid …